The Hurun Research Institute today, in association with Jiaxing City in East China, released the 2022 Hurun Global 500, a list of the 500 most valuable non-state-controlled companies in the world.

Hurun Report released the Hurun Global Rich List 2022, a ranking of the US dollar billionaires in the world. Wealth calculations are a snapshot of 14 January 2022. This is the eleventh year of the ranking.

On 1 December 2021, WHO is calling on global leaders and citizens to rally to confront the inequalities that drive AIDS and to reach people who are currently not receiving essential HIV services.

August 20, the Hurun Research Institute in association with Jiaxing City released the 2021 Hurun Global 500.

The novel coronavirus pandemic has presented the global pharma industry with a double challenge:to develop potential treatments and preventative vaccines, and continue to meet the existing needs of healthcare providers and patients, all at

The global urinalysis market is expected to grow at a CAGR of 7.5% from 2018 to 2022 to reach a value of USD 2.14 billion by 2022, driven by a large base of the target population and increasing demand for urinalysis due to unmet clinical ne

The global in vitro diagnostics market was valued at USD 55.00 million in 2016 and is projected to grow at a healthy CAGR of 5.60% between 2017 and 2025 to reach USD 89.8 million by the end of 2025. The market growth will be driven by the ri

The global point of care (POC) molecular diagnostics market is expected to grow at a CAGR of close to 14% during the period 2019-2023, driven mainly by the growing number of MAs and collaborations, and rising focus on next-generation product

The global urinalysis market is expected to grow at a steady CAGR of 5.40% over the 2016-2024 period to reach a value of USD 1.5 billion by the end of 2024, propelled mainly by the rising incidence of diabetes and urinal infections, globally

The global point of care (POC) urinalysis market is projected to grow at a CAGR of more than 3% over the 2018-2022 period, driven mainly by the rising prevalence of nephropathic disorders and urinary tract infections (UTIs) which is generati